About Exo
Exo is a company based in Redwood City (United States) founded in 2015 by Sandeep Akkaraju, John Kokulis, Janusz Bryzek, and Yusuf Haque. It operates as a AI-as-a-Service, Direct-to-Consumer (D2C), and HealthTech. Exo has raised $463.39 million across 11 funding rounds from investors including Applied Materials, BlackRock and RA Capital. Exo has completed 1 acquisition, including MEDO. Exo offers products and services including Exo Iris, Exo Works, Exo AI, and SweepAI. Exo operates in a competitive market with competitors including Butterfly Network, SonoSite, EchoNous, Zonare Medical Systems and TechsoMed, among others.
- Headquarter Redwood City, United States
- Founders Sandeep Akkaraju, John Kokulis, Janusz Bryzek, Yusuf Haque
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Exo Imaging, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$463.39 M (USD)
in 11 rounds
-
Latest Funding Round
$43.94 M (USD), Series C
May 28, 2025
-
Investors
Applied Materials
& 19 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Exo
Exo offers a comprehensive portfolio of products and services, including Exo Iris, Exo Works, Exo AI, and SweepAI.
Handheld ultrasound device used for point-of-care imaging.
Software designed for ultrasound scanning and documentation.
AI tool used for automated ultrasound diagnostics.
AI technology used for real-time ultrasound insights.
People of Exo
Unlock access to complete
Unlock access to complete
Funding Insights of Exo
Exo has successfully raised a total of $463.39M across 11 strategic funding rounds. The most recent funding activity was a Series C round of $43.94 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Exo
Exo has secured backing from 20 investors, including institutional and venture fund investors. Prominent investors backing the company include Applied Materials, BlackRock and RA Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services are provided focusing on healthcare innovation.
|
Locked | Locked | Locked | |
|
Growth stage tech & life sciences focused VC Firm investing in Asia and the US
|
Locked | Locked | Locked | |
|
Early-stage tech startups are invested in globally by TDK Ventures.
|
Locked | Locked | Locked |
Investor details for Exo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Exo
Exo has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include MEDO.
Investment portfolio details for Exo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI-augmented 3D ultrasound devices are developed for point-of-care diagnostics.
|
Locked | Locked | 2017 | Locked |
Complete acquisition details for Exo
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Exo
Detailed financials for Exo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Exo Comparisons
Peer comparison for Exo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Exo
Exo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Butterfly Network, SonoSite, EchoNous, Zonare Medical Systems and TechsoMed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Handheld ultrasound devices are developed for whole-body medical imaging.
|
|
| Locked | Locked | Locked |
Hand-carried ultrasound systems for medical specialties are developed and distributed.
|
|
| Locked | Locked | Locked |
AI-assisted handheld ultrasound devices are provided for medical diagnostics.
|
|
| Locked | Locked | Locked |
Portable ultrasound systems are developed and provided for medical use.
|
|
| Locked | Locked | Locked |
Ultrasound-based monitoring systems for thermal ablation procedures are developed.
|
Detailed competitors of Exo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Exo
Complete news archive for Exo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Exo
Exo was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Exo is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Sandeep Akkaraju is the current CEO of Exo. They have also founded this company.
Exo is a funded company, having raised a total of $463.39M across 11 funding rounds to date.
Exo is engaged in creating a point-of-care ultrasound (POCUS) ecosystem that enables caregivers to access medical imaging anywhere. The company offers handheld ultrasound devices like Exo Iris, powered by advanced AI for high-performance imaging. Solutions such as Exo Works streamline scanning, documentation, and billing processes. Additionally, Exo AI and SweepAI provide real-time diagnostic insights for cardiac and lung conditions. Operating in the healthcare sector, Exo targets medical professionals and institutions with innovative tools to improve diagnostic accuracy and patient outcomes.
Exo's top competitors include Butterfly Network, TechsoMed and EchoNous.
Exo offers Exo Iris, Exo Works, Exo AI, and SweepAI.
Exo has made 1 acquisition, including MEDO.
Exo has 20 investors. Key investors include Applied Materials, BlackRock, RA Capital, Sony Innovation Fund, and OSF HealthCare.